Pneumothorax Clinical Trials
3 recruiting trials for Pneumothorax. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Pneumothorax clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Brigham and Women's Hospital (1), National Heart, Lung, and Blood Institute (NHLBI) (1), Assiut University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Portable Dynamic Digital Radiography (DDR) (diagnostic_test, 1 trial), followed by Toshibia Aquilion One CT, Lung Ultrasound.
Track Pneumothorax trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
Dynamic digital radiography (DDR) is a new advanced version of chest radiography that captures dynamic images at a rate of 15 frames per second. It is coupled with an analytical...
Study of the Disease Process of Lymphangioleiomyomatosis
Pulmonary lymphangioleiomyomatosis (LAM) is a destructive lung disease typically affecting women of childbearing age. Currently, there is no effective therapy for the disease and...
Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Pneumothorax, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pneumothorax, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pneumothorax, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.